Join
Live feed
·
INSIDERFilingvia Quantisnow
Arcadia Biosciences Inc. logo

Chief Financial Officer Kawakami Mark bought $1,743 worth of shares (700 units at $2.49), increasing direct ownership by 35% to 2,681 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RKDA· Arcadia Biosciences Inc.
Consumer Staples
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RKDA (Arcadia Biosciences Inc.) and more on Quantisnow.